Retraction Note: Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model

Detalles Bibliográficos
Autores principales: Qiao, H., Wang, T. Y., Yu, Z. F., Han, X. G., Liu, X. Q., Wang, Y. G., Fan, Q. M., Qin, A., Tang, T. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Retraction Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506481/
https://www.ncbi.nlm.nih.gov/pubmed/31068574
http://dx.doi.org/10.1038/s41419-019-1606-1
_version_ 1783416860406972416
author Qiao, H.
Wang, T. Y.
Yu, Z. F.
Han, X. G.
Liu, X. Q.
Wang, Y. G.
Fan, Q. M.
Qin, A.
Tang, T. T.
author_facet Qiao, H.
Wang, T. Y.
Yu, Z. F.
Han, X. G.
Liu, X. Q.
Wang, Y. G.
Fan, Q. M.
Qin, A.
Tang, T. T.
author_sort Qiao, H.
collection PubMed
description
format Online
Article
Text
id pubmed-6506481
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-65064812019-05-09 Retraction Note: Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model Qiao, H. Wang, T. Y. Yu, Z. F. Han, X. G. Liu, X. Q. Wang, Y. G. Fan, Q. M. Qin, A. Tang, T. T. Cell Death Dis Retraction Note Nature Publishing Group UK 2019-05-08 /pmc/articles/PMC6506481/ /pubmed/31068574 http://dx.doi.org/10.1038/s41419-019-1606-1 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Retraction Note
Qiao, H.
Wang, T. Y.
Yu, Z. F.
Han, X. G.
Liu, X. Q.
Wang, Y. G.
Fan, Q. M.
Qin, A.
Tang, T. T.
Retraction Note: Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model
title Retraction Note: Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model
title_full Retraction Note: Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model
title_fullStr Retraction Note: Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model
title_full_unstemmed Retraction Note: Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model
title_short Retraction Note: Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model
title_sort retraction note: structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets jnk/erk to synergistically attenuate osteoclastogenesis in a breast cancer model
topic Retraction Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506481/
https://www.ncbi.nlm.nih.gov/pubmed/31068574
http://dx.doi.org/10.1038/s41419-019-1606-1
work_keys_str_mv AT qiaoh retractionnotestructuralsimulationofadenosinephosphateviaplumbaginandzoledronicacidcompetitivelytargetsjnkerktosynergisticallyattenuateosteoclastogenesisinabreastcancermodel
AT wangty retractionnotestructuralsimulationofadenosinephosphateviaplumbaginandzoledronicacidcompetitivelytargetsjnkerktosynergisticallyattenuateosteoclastogenesisinabreastcancermodel
AT yuzf retractionnotestructuralsimulationofadenosinephosphateviaplumbaginandzoledronicacidcompetitivelytargetsjnkerktosynergisticallyattenuateosteoclastogenesisinabreastcancermodel
AT hanxg retractionnotestructuralsimulationofadenosinephosphateviaplumbaginandzoledronicacidcompetitivelytargetsjnkerktosynergisticallyattenuateosteoclastogenesisinabreastcancermodel
AT liuxq retractionnotestructuralsimulationofadenosinephosphateviaplumbaginandzoledronicacidcompetitivelytargetsjnkerktosynergisticallyattenuateosteoclastogenesisinabreastcancermodel
AT wangyg retractionnotestructuralsimulationofadenosinephosphateviaplumbaginandzoledronicacidcompetitivelytargetsjnkerktosynergisticallyattenuateosteoclastogenesisinabreastcancermodel
AT fanqm retractionnotestructuralsimulationofadenosinephosphateviaplumbaginandzoledronicacidcompetitivelytargetsjnkerktosynergisticallyattenuateosteoclastogenesisinabreastcancermodel
AT qina retractionnotestructuralsimulationofadenosinephosphateviaplumbaginandzoledronicacidcompetitivelytargetsjnkerktosynergisticallyattenuateosteoclastogenesisinabreastcancermodel
AT tangtt retractionnotestructuralsimulationofadenosinephosphateviaplumbaginandzoledronicacidcompetitivelytargetsjnkerktosynergisticallyattenuateosteoclastogenesisinabreastcancermodel

Ejemplares similares